leadf
logo-loader
viewSourceBio International PLC
(
AIM:SBI
)

SourceBio International shares defy the gloom to move to a premium on their AIM debut

At 9am the stock was up 11p at 173p, providing those who backed the float with a modest early profit on their investment

xxxxx

Lab services specialist SourceBio International plc (LON:SBI) defied the early gloom to get off to a premium start on its first day of trading on AIM.

At 9 am the stock was up 11p at 173p, providing those who backed the float with a modest early profit on their investment.

For the business, the £35mln raised will be used to scale up COVID-19 testing capacity as well as paying off shareholder and bank loans.

The positive debut has added around £8mln to SourceBio’s initial £120mln market capitalisation.

Chairman Jay LeCoque said: "We are delighted by the strong support we've received from new institutional investors and our existing shareholders.

“Our IPO on AIM allows us to significantly increase our COVID-19 testing capacity, accelerate earnings growth in our core business and execute on potential M&A opportunities.

“It's an exciting time for our business and we look forward to executing on our ambitious growth plans and delivering value to our shareholders."

Quick facts: SourceBio International PLC

Follow
AIM:SBI

Price: 127 GBX

Market Cap: £94.21 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

FTSE falls deeper into the sea of red as China induced tsunami hits Asian...

FTSE 100 hit more turbulence as China’s clampdown on tech firms continued to hit Asian markets. In London, the blue chip index shed 48 to 6,976. Tesla profits surged ahead in its latest quarter despite shortages of semiconductor chips and distribution problems. Sales jumped to US$12bn with a...

on 27/7/21

2 min read